Skip to main content

2 Result(s)

within P Cassileth Remove this filter

and

  1. No Access

    Article

    Interleukin-2 and leukemia

    Leukemia has been treated with chemotherapy for the past 40 years with only moderate success. A growing body of evidence suggests that by augmenting the immune system more effective results may be obtained. Th...

    M Goodman, L Cabral, P Cassileth in Leukemia (1998)

  2. No Access

    Chapter and Conference Paper

    Phase III Evaluation of Low-Dose Cytosine Arabinoside Versus Supportive Care in the Treatment of Adults With Myelodysplastic Syndrome: An Intergroup Study by the Eastern Cooperative Oncology Group and the Southwest Oncology Group—Preliminary Results

    The myelodysplastic syndromes are a heterogeneous group of malignant bone marrow disorders affecting predominant patients over the age of 60 and are characterized by symptomatic anemia, leukopenia, or thromboc...

    J. M. Bennett, K. B. Miller, K. Kim, F. S. Morrison… in Myelodysplastic Syndromes (1992)